BACKGROUND: The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes. METHODS AND FINDINGS: A pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analysis. MGIT960 technique was compared with the Lowenstein-Jensen (LJ) method for laboratory diagnosis of active TB. Primary outcome was the proportion of patients who had their initial medical management changed within 2 months after random...
Background : Tuberculosis (TB) is a major health problem, and accurate and rapid diagnosis of multid...
Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2...
BACKGROUND: Estimates of month-2 culture conversion, a proxy indicator of tuberculosis (TB) treatmen...
<div><p>Background</p><p>The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was reco...
The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. H...
Background The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO...
Background: Tuberculosis kills more people than any other infectious disease, and new regimens are ...
Tuberculosis (TB) poses a significant challenge for global health. Developing countries most burdene...
Abstract: Background: Routine tuberculosis culture remains unavailable in many high-burden areas, in...
SummaryObjectiveTo evaluate the diagnostic performance of two liquid-phase culture media for the dia...
BackgroundTuberculosis kills more people than any other infectious disease, and new regimens are ess...
BACKGROUND: This study compares Mycobacterium tuberculosis culture isolation and drug sensitivity te...
BACKGROUND: Routine tuberculosis culture remains unavailable in many high-burden areas, including Ta...
BACKGROUND: Effective strategies are needed to facilitate the prompt diagnosis and treatment of tube...
Supported by the European and Developing Country Clinical Trials Partnership (grant IP.2007.32011.01...
Background : Tuberculosis (TB) is a major health problem, and accurate and rapid diagnosis of multid...
Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2...
BACKGROUND: Estimates of month-2 culture conversion, a proxy indicator of tuberculosis (TB) treatmen...
<div><p>Background</p><p>The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was reco...
The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. H...
Background The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO...
Background: Tuberculosis kills more people than any other infectious disease, and new regimens are ...
Tuberculosis (TB) poses a significant challenge for global health. Developing countries most burdene...
Abstract: Background: Routine tuberculosis culture remains unavailable in many high-burden areas, in...
SummaryObjectiveTo evaluate the diagnostic performance of two liquid-phase culture media for the dia...
BackgroundTuberculosis kills more people than any other infectious disease, and new regimens are ess...
BACKGROUND: This study compares Mycobacterium tuberculosis culture isolation and drug sensitivity te...
BACKGROUND: Routine tuberculosis culture remains unavailable in many high-burden areas, including Ta...
BACKGROUND: Effective strategies are needed to facilitate the prompt diagnosis and treatment of tube...
Supported by the European and Developing Country Clinical Trials Partnership (grant IP.2007.32011.01...
Background : Tuberculosis (TB) is a major health problem, and accurate and rapid diagnosis of multid...
Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2...
BACKGROUND: Estimates of month-2 culture conversion, a proxy indicator of tuberculosis (TB) treatmen...